Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study.
Mild disability
Multiple sclerosis
Self-perceived Quality of Life
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
25 Mar 2024
25 Mar 2024
Historique:
received:
12
11
2023
accepted:
06
02
2024
revised:
05
02
2024
medline:
25
3
2024
pubmed:
25
3
2024
entrez:
25
3
2024
Statut:
aheadofprint
Résumé
While the determinants influencing self-perceived health-related quality of life (spHRQoL) in persons with multiple sclerosis (pwMS) and severe physical impairment have been well investigated, their impact on pwMS with mild disability is poorly addressed. We aimed to investigate possible drivers of spHRQoL among Sardinian pwMS with an EDSS lower than 2.5. A sample of 87 fully ambulatory (EDSS < 2.5) pwMS were included after screening for major cognitive impairment. spHRQoL was measured with the Italian version of 36-Item Short Form Health Survey (SF-36). The Physical Component Summary (PCS) and Mental Component Summary (MCS) were used as dependent variables for univariate analysis with Cognitive Behavioral Assessment (CBA) and specific individual factors as independent variables. Subsequent multivariate general linear models (GLMs) for PCS and MCS respectively were run after stepwise regression. Normative data referring to Italian population were used for comparison. As compared to normative data, no statistically significant difference was found for PCS, while MCS was reduced. Multivariate GLMs showed a significant association between lower PCS scores and presence of psychosomatic symptoms, older age and fatigue (p < 0.05). Furthermore, a significant association was shown between lower MCS scores and presence of anxiety (p < 0.001). Mood, presence of psychosomatic symptoms, fatigue and age can have a relevant impact on spHRQoL in people with mildly disabling MS and should be considered in the management of such individuals.
Identifiants
pubmed: 38526763
doi: 10.1007/s00415-024-12244-0
pii: 10.1007/s00415-024-12244-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Références
Marrie RA, O’Mahony J, Maxwell C et al (2018) Canadian pediatric demyelinating disease network. Incidence and prevalence of MS in children: a population-based study in Ontario, Canada. Neurology 91:e1579–e1590
doi: 10.1212/WNL.0000000000006395
pubmed: 30258022
Thompson AJ, Baranzini SE, Geurts J et al (2018) Multiple sclerosis. Lancet 391:1622–1636
doi: 10.1016/S0140-6736(18)30481-1
pubmed: 29576504
Haraldstad K, Wahl A, Andenæs R et al (2019) A systematic review of quality of life research in medicine and health sciences. Qual Life Res 28(10):2641–2650
doi: 10.1007/s11136-019-02214-9
pubmed: 31187410
pmcid: 6761255
McKay KA, Ernstsson O, Manouchehrinia A et al (2020) Determinants of quality of life in pediatric- and adult-onset multiple sclerosis. Neurology 94(9):e932–e941
doi: 10.1212/WNL.0000000000008667
pubmed: 31732567
pmcid: 7238943
Yalachkov Y, Soydaş D, Bergmann J et al (2019) Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Mult Scler Relat Disord 30:33–37
doi: 10.1016/j.msard.2019.01.049
pubmed: 30735970
Benito-León J, Morales JM, Rivera-Navarro J (2002) Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 9(5):497–502
doi: 10.1046/j.1468-1331.2002.00450.x
pubmed: 12220381
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517
doi: 10.1016/S0140-6736(08)61620-7
pubmed: 18970977
Pugliatti M, Cossu P, Sotgiu S et al (2009) Clustering of multiple sclerosis, age of onset and gender in Sardinia. J Neurol Sci 286(1–2):6–13
doi: 10.1016/j.jns.2009.07.013
pubmed: 19674758
Urru SA, Antonelli A, Sechi GM et al (2020) Prevalence of multiple sclerosis in Sardinia: a systematic cross-sectional multi-source survey. Mult Scler 26(3):372–380
doi: 10.1177/1352458519828600
pubmed: 30793660
Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302
doi: 10.1002/ana.22366
pubmed: 21387374
pmcid: 3084507
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
doi: 10.1212/WNL.33.11.1444
pubmed: 6685237
Raven JC, Court JH, Raven J (1990) Manual for Raven’s progressive matrices and vocabulary scales. Section 2 coloured progressive matrices (1990 edition, with US norms). Oxford Psychologists Press, Oxford
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care 30:473–483
doi: 10.1097/00005650-199206000-00002
pubmed: 1593914
Sanavio E, Bertolotti G, Michielin P et al (1997) Cognitive behavioural assessment 2.0 (Italian version). Organizzazioni Speciali, Firenze
Apolone G, Cifani S, Mosconi P (1997) Questionario sullo stato di salute SF36. Traduzione e validazione della versione italiana: Risultati del progetto IQOLA. Medic 2:86–94
Apolone G, Mosconi P (1998) The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036
doi: 10.1016/S0895-4356(98)00094-8
pubmed: 9817120
Nortvedt MW, Riise T (2003) The use of quality of life measures in multiple sclerosis research. Mult Scler 9(1):63–72
doi: 10.1191/1352458503ms871oa
pubmed: 12617271
Ware JE (1993) SF-36 Health Survey. Manual and interpretation guide. Health Institute, New England Medical Center, Boston
Cioncoloni D, Innocenti I, Bartalini S et al (2014) Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants. J Neurol Sci 345(1–2):213–219
doi: 10.1016/j.jns.2014.07.050
pubmed: 25130927
Eysenck HJ, Eysenck SBG (1975) Manual of the Eysenck personality questionnaire. University of London, London
Dominguez RA, Jacobson AF, de la Gandara J et al (1989) Drug response assessed by the Modified Maudsley Obsessive-Compulsive Inventory. Psychopharmacol Bull 25:215–218
pubmed: 2602515
Benedict RH, Wahlig E, Bakshi R et al (2005) Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 231(1–2):29–34
doi: 10.1016/j.jns.2004.12.009
pubmed: 15792817
Buhse M, Banker WM, Clement LM (2014) Factors associated with health-related quality of life among older people with multiple sclerosis. Int J MS Care 16(1):10–19
doi: 10.7224/1537-2073.2012-046
pubmed: 24688350
pmcid: 3967699
Benedict RHB, Amato MP, DeLuca J et al (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19(10):860–871
doi: 10.1016/S1474-4422(20)30277-5
pubmed: 32949546
pmcid: 10011205
Possa MF, Minacapelli E, Canale S et al (2017) The first year after diagnosis: psychological impact on people with multiple sclerosis. Psychol Health Med 22(9):1063–1071
doi: 10.1080/13548506.2016.1274043
pubmed: 28058855
Sehanovic A, Kunic S, Ibrahimagic OC et al (2020) Contributing factors to the quality of life in multiple sclerosis. Med Arch 74(5):368–373. https://doi.org/10.5455/medarh.2020.74.368-373
doi: 10.5455/medarh.2020.74.368-373
pubmed: 33424092
pmcid: 7780794
Højsgaard Chow H, Schreiber K, Magyari M et al (2018) Progressive multiple sclerosis, cognitive function, and quality of life. Brain Behav 8(2):e00875
doi: 10.1002/brb3.875
pubmed: 29484253
pmcid: 5822575
Goldman MD, LaRocca NG, Rudick RA et al (2019) Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data. Neurology 93(21):e1921–e1931
doi: 10.1212/WNL.0000000000008519
pubmed: 31641014
pmcid: 6885577
Pugliatti M, Riise T, Nortvedt MW et al (2008) Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients. J Neurol 255(2):157–162
doi: 10.1007/s00415-008-0543-1
pubmed: 18283408
Amato MP, Ponziani G, Rossi F et al (2001) Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 7(5):340–344
doi: 10.1177/135245850100700511
pubmed: 11724451
Binzer S, McKay KA, Brenner P et al (2019) Disability worsening among persons with multiple sclerosis and depression: a Swedish cohort study. Neurology 93(24):e2216–e2223
doi: 10.1212/WNL.0000000000008617
pubmed: 31704791
pmcid: 6937491
Prisnie JC, Sajobi TT, Wang M et al (2018) Effects of depression and anxiety on quality of life in five common neurological disorders. Gen Hosp Psychiatry 52:58–63
doi: 10.1016/j.genhosppsych.2018.03.009
pubmed: 29684713
Dubayova T, Krokavcova M, Nagyova I et al (2013) Type D, anxiety and depression in association with quality of life in patients with Parkinson’s disease and patients with multiple sclerosis. Qual Life Res 22(6):1353–1360
doi: 10.1007/s11136-012-0257-9
pubmed: 23054489
Marrie RA (2017) Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol 13(6):375–382
doi: 10.1038/nrneurol.2017.33
pubmed: 28303911
Zarbo IR, Minacapelli E, Falautano M et al (2016) Personality traits predict perceived health-related quality of life in persons with multiple sclerosis. Mult Scler 22(4):551–558
doi: 10.1177/1352458515594045
pubmed: 26163067
Maggio MG, Cuzzola MF, Latella D et al (2020) How personality traits affect functional outcomes in patients with multiple sclerosis: a scoping review on a poorly understood topic. Mult Scler Relat Disord 46:102560
doi: 10.1016/j.msard.2020.102560
pubmed: 33049463
Eysenck HJ (1946) The measurement of personality (Resume). Proc R Soc Med 40:75–80
pubmed: 19993450
pmcid: 2182199
Casetta I, Riise T, Wamme Nortvedt M et al (2009) Gender differences in health-related quality of life in multiple sclerosis. Mult Scler 15(11):1339–1346
doi: 10.1177/1352458509107016
pubmed: 19797452
Braley TJ, Chervin RD (2010) Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. Sleep 33(8):1061–1067
doi: 10.1093/sleep/33.8.1061
pubmed: 20815187
pmcid: 2910465